IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Cheng who wrote (1046)	6/25/1997 3:11:00 PM
From: I. Luttichuys	of 1762

Don, notice that the article and IDPH's and SBH's announcement leave room for hope that CE9.1 may be continued after the cause of the CD4 cell depletion is discovered. If my source is to be trusted (he is very knowlegable in such technology and his opinion is the reason I earlier announced my decision to sell on this thread) CE9.1 will be completely abandoned. I this happens, we will have another, more negative press release. The market's reaction may or may not be worse than it was for this last release and the influence of IDEC's being so close to approval for C2B8 may or may not help. I am a little more pessimistic than when I posted yesterday and, in the near term I do hope we can move up on the influence of C2B8 but, I wonder if Vestor has the right approach at this time. I think there is a real possibility at this time that CE9.1 will be permanently abandoned. BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next